Clinical Trial Update: Minocycline for the Treatment of Early-Phase Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating minocycline for negative and cognitive symptoms in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Shalvata Mental Health Center | Conditions: Negative and Cognitive Symptoms in Schizophrenia | Phase 3 | Status: COMPLETED